Other
Neoplasm by Morphology
CI-CAN-00000002Explore in graph →
Non-malignant13,328 active trials222 approved drugs2,775 evidence items
- NCIt
- C4741
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000002Explore in graph →
Clinical trials
52,686 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00091663 | A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 5,000 | Genentech, Inc.INDUSTRY | 1 | Mar 4, 2014 | clinicaltrials |
| NCT00022737 | Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia | completed | Phase 3 | 220 | National Cancer Institute (NCI)NIH | 1 | Feb 27, 2014 | clinicaltrials |
| NCT00367861 | Prospective Multicentric Randomized Study of Glivec® in Advanced GIST Expressing C-kit: Interruption After 5 Years vs Maintenance | completed | Phase 3 | 564 | Centre Leon BerardOTHER | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00005603 | Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia | completed | Phase 3 | 276 | Children's Oncology GroupNETWORK | 1 | Feb 20, 2014 | clinicaltrials |
| NCT00015873 | Comparison of Different Combination Chemotherapy Regimens in Treating Infants With Acute Lymphoblastic Leukemia | completed | Phase 3 | 350 | Dutch Childhood Oncology GroupOTHER | 11 | Feb 17, 2014 | clinicaltrials |
| NCT01040780 | Safety and Efficacy Study of Icotinb in Non-small Cell Lung Cancer (NSCLC) Patients(ICOGEN) | completed | Phase 3 | 399 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Feb 14, 2014 | clinicaltrials |
| NCT00073307 | Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer | completed | Phase 3 | 903 | BayerINDUSTRY | 19 | Feb 6, 2014 | clinicaltrials |
| NCT00869635 | S-1 and Photodynamic Therapy in Cholangiocarcinoma | completed | Phase 3 | 43 | Asan Medical CenterOTHER | 1 | Feb 6, 2014 | clinicaltrials |
| NCT00989131 | Study of Paclitaxel in Patients With Ovarian Cancer | completed | Phase 3 | 789 | Oasmia Pharmaceutical ABINDUSTRY | 16 | Feb 4, 2014 | clinicaltrials |
| NCT00004196 | Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis | completed | Phase 3 | 3,000 | University of Alabama at BirminghamOTHER | 1 | Jan 20, 2014 | clinicaltrials |
| NCT00390806 | Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer | completed | Phase 3 | 472 | GlaxoSmithKlineINDUSTRY | 6 | Jan 20, 2014 | clinicaltrials |
| NCT00387764 | Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer | completed | Phase 3 | 80 | GlaxoSmithKlineINDUSTRY | 20 | Jan 14, 2014 | clinicaltrials |
| NCT01819389 | Low-dose Nilotinib and Imatinib Combination in Chronic Myeloid Leukemia Patients, With Failure, Suboptimal Response or Treatment Intolerance | completed | Phase 3 | 10 | Hospital Universitario Dr. Jose E. GonzalezOTHER | 1 | Jan 7, 2014 | clinicaltrials |
| NCT00016263 | Dacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant Melanoma | completed | Phase 3 | — | Genta IncorporatedINDUSTRY | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00024440 | Fludarabine and Cyclophosphamide With or Without Oblimersen in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia | completed | Phase 3 | — | Genta IncorporatedINDUSTRY | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00428558 | Timed-Sequential Induction in CBF-AML | completed | Phase 3 | 200 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Dec 20, 2013 | clinicaltrials |
| NCT00494299 | Phase III Study of BAY43-9006 in Patients With Advanced Hepatocellular Carcinoma (HCC) Treated After Transcatheter Arterial Chemoembolization (TACE) | completed | Phase 3 | 458 | BayerINDUSTRY | 2 | Dec 20, 2013 | clinicaltrials |
| NCT00002892 | Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma | completed | Phase 3 | 1,000 | Institute of Cancer Research, United KingdomOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00005863 | Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia | completed | Phase 3 | — | Medical Research CouncilOTHER_GOV | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00006231 | Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malignant Mesothelioma | completed | Phase 3 | 44 | University of GlasgowOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00004218 | Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia | completed | Phase 3 | — | Leukemia Research FundOTHER | 8 | Dec 18, 2013 | clinicaltrials |
| NCT00005823 | Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome | completed | Phase 3 | 2,000 | Leukemia Research FundOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00565019 | Effects of Steroid Injection With Percutaneous Needle Aponeurotomy in Dupuytren's Contracture | completed | Phase 3 | 51 | Sunnybrook Health Sciences CentreOTHER | 1 | Dec 13, 2013 | clinicaltrials |
| NCT01005680 | A Study Comparing Two Different Chemotherapy Types in Chinese Patients With Advanced Non Small Cell Lung Cancer | completed | Phase 3 | 256 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 13, 2013 | clinicaltrials |
| NCT01460706 | Imaging Malignant Glioma With 68Ga-DOTATOC PET/CT(DOTAGLI) | completed | Phase 2 / Phase 3 | 30 | Turku University HospitalOTHER_GOV | 1 | Dec 12, 2013 | clinicaltrials |
| NCT00003014 | Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular Cancer | completed | Phase 3 | 800 | Medical Research CouncilOTHER_GOV | 7 | Dec 4, 2013 | clinicaltrials |
| NCT00003421 | Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease | completed | Phase 3 | 800 | Medical Research CouncilOTHER_GOV | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00003436 | Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia | completed | Phase 3 | 2,000 | Medical Research CouncilOTHER_GOV | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00349492 | A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung Cancer | completed | Phase 3 | 372 | Clinical Research Center for Solid Tumor, KoreaOTHER | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00357474 | Comparison Study of Transarterial Chemoembolization and Percutaneous Ethanol Injection for Multiple, Small HCCs | completed | Phase 3 | 22 | Seoul National University HospitalOTHER | 1 | Dec 4, 2013 | clinicaltrials |
| NCT01998503 | Bortezomib and Dexamethasone Followed by ASCT Compared With ASCT Alone in Treating Patients With AL Amyloidosis | completed | Phase 3 | 56 | Nanjing University School of MedicineOTHER | 1 | Nov 29, 2013 | clinicaltrials |
| NCT00165282 | Mindfulness Meditation in Bone Marrow Transplantation | completed | Phase 2 / Phase 3 | 241 | Emory UniversityOTHER | 1 | Nov 28, 2013 | clinicaltrials |
| NCT00968838 | A Study for Leukemia Patients With Life-Threatening Infections | completed | Phase 3 | 178 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 26, 2013 | clinicaltrials |
| NCT00205751 | Thalidomide/Dexamethasone vs MP for Induction Therapy and Thalidomide/Intron A vs Intron A for Maintenance Therapy | completed | Phase 2 / Phase 3 | 350 | Austrian Forum Against CancerOTHER | 1 | Nov 25, 2013 | clinicaltrials |
| NCT00205764 | Tandem High Dose Melphalan Versus Triple Intermediate Dose Melphalan and Stem Cell Transplantation in Induction Phase and Prednisolone/IFN Versus IFN in Maintenance Therapy | completed | Phase 3 | 212 | Austrian Forum Against CancerOTHER | 1 | Nov 25, 2013 | clinicaltrials |
| NCT00474786 | Temsirolimus Versus Sorafenib As Second-Line Therapy In Patients With Advanced RCC Who Have Failed First-Line Sunitinib(INTORSECT) | completed | Phase 3 | 512 | PfizerINDUSTRY | 20 | Nov 21, 2013 | clinicaltrials |
| NCT01110824 | Prevention of Left Ventricular Dysfunction During Chemotherapy(OVERCOME) | completed | Phase 3 | 90 | Hospital Clinic of BarcelonaOTHER | 1 | Nov 15, 2013 | clinicaltrials |
| NCT00322452 | First Line IRESSA™ Versus Carboplatin/Paclitaxel in Asia(IPASS) | completed | Phase 3 | 1,329 | AstraZenecaINDUSTRY | 9 | Nov 7, 2013 | clinicaltrials |
| NCT00003991 | Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia | completed | Phase 3 | 360 | Maxim PharmaceuticalsINDUSTRY | 12 | Nov 6, 2013 | clinicaltrials |
| NCT00112554 | Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia | completed | Phase 3 | 420 | Vion PharmaceuticalsINDUSTRY | 10 | Nov 6, 2013 | clinicaltrials |
| NCT01528488 | Prophylactic EVOZAC® Calming Skin Spray for EGFR-TKIs Associated Rash Eruption in NSCLC | completed | Phase 2 / Phase 3 | 118 | Sun Yat-sen UniversityOTHER | 1 | Nov 5, 2013 | clinicaltrials |
| NCT00457392 | A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone | completed | Phase 3 | 960 | PfizerINDUSTRY | 26 | Oct 29, 2013 | clinicaltrials |
| NCT00298415 | Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC) | completed | Phase 3 | 451 | Intergroupe Francophone de Cancerologie ThoraciqueOTHER | 1 | Oct 25, 2013 | clinicaltrials |
| NCT00070187 | Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma | completed | Phase 2 / Phase 3 | 24 | Children's Oncology GroupNETWORK | 3 | Oct 17, 2013 | clinicaltrials |
| NCT00382031 | Zalutumumab in Patients With Non-curable Head and Neck Cancer | completed | Phase 3 | 286 | GenmabINDUSTRY | 12 | Oct 15, 2013 | clinicaltrials |
| NCT00333840 | Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia | completed | Phase 3 | 1,106 | Novartis PharmaceuticalsINDUSTRY | 16 | Oct 14, 2013 | clinicaltrials |
| NCT00003835 | Combination Chemotherapy in Treating Patients With Stage III Colon Cancer | completed | Phase 3 | 1,260 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2013 | clinicaltrials |
| NCT01147939 | Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)(CLAVELA) | completed | Phase 3 | 381 | Clavis PharmaINDUSTRY | 13 | Sep 27, 2013 | clinicaltrials |
| NCT00281918 | Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia(CLL-8) | completed | Phase 3 | 817 | Hoffmann-La RocheINDUSTRY | 11 | Sep 19, 2013 | clinicaltrials |
| NCT00005589 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma | completed | Phase 3 | 460 | EBMT Solid Tumors Working PartyOTHER | 17 | Sep 17, 2013 | clinicaltrials |
Data updated 24 days agoSource updated Mar 4, 2014source: clinicaltrials